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Background: Psychosocial problems are more prevalent among patients with chronic diseases than among the
general population. They may lead to a downward spiral of poor adherence, deterioration of the condition and decline
in daily functioning. In addition to medical management, systematic attention to emotional and role management
tasks during routine chronic care seems mandatory. We intend to integrate an existing nurse-led minimal
psychological intervention to support patients’ self-management, which appeared to be effective and cost-effective, in
routine care by primary care nurses, so we adjusted it to fit the host setting. The resulting Self-Management Support
(SMS) programme involves early detection of patients with emotional distress and problems of daily functioning, as
well as self-management support through problem solving and reattribution techniques. Strategies to embed SMS in
daily practice include training and booster sessions for practice nurses as well as organisational and financial
arrangements. This study aims to simultaneously evaluate the implementation process and effects of SMS in routine
care, using a hybrid effectiveness–implementation design.
Methods/Design: Registration data, questionnaires and interviews will be used to explore the facilitators, barriers and
costs regarding successful implementation of SMS. The effects of SMS will be evaluated in a pragmatic cluster-
randomised controlled trial with a baseline measurement and follow-up measurements after 4 and 12 months. The
population will consist of 46 practice nurses and their type 2 diabetes patients (N = 460; 10 per practice nurse). The
practice nurses will be randomly assigned to the intervention or control group. Practice nurses of the intervention
group will receive SMS training. Patients for the intervention and control groups will be recruited by a researcher-led
self-administered screening procedure to decide which patients of those scheduled for routine consultation are likely
to be detected by the practice nurses as eligible for the self-management support. Primary outcome measure is
patients’ daily functioning. Secondary measures include emotional well-being, participation, autonomy and control over
the disease.
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Discussion: Our hybrid study design is complicated by the detection method used by the practice nurses. This method
is an implementation issue in itself that has consequences for the realisation and power of the effect evaluation.
Trial registration: Current Controlled Trials, NTR2764
Keywords: Hybrid Effectiveness–Implementation Design, Primary Care, Chronic Disease, Psychosocial Problems,
Self-Management, Practice NurseBackground
The prevalence rate of psychosocial problems is higher
among patients with chronic somatic diseases than among
the general population [1-4]. Problems like depression or
distress may hamper the ability to manage a chronic con-
dition [5]. A reciprocal relationship has been suggested:
emotional distress may interfere with control over the dis-
ease, and at the same time, poor control over the disease
can lead to emotional distress. Persistent negative feelings
have implications for adherence to medication and lifestyle
regiments, motivation, self-efficacy and problem solving
[6,7]. Patients therefore face not only the day-to-day med-
ical management, but also the challenge to deal with their
emotions and problems of daily functioning in order to re-
main in control of their illness [6,8]. To improve the out-
comes of chronic care, Lorig and Holman argue that three
self-management tasks should be addressed in primary
care: medical management, emotional management and
role management [8]. However, Dutch guidelines for the
care of chronic diseases like type 2 diabetes mellitus pri-
marily focus on medical and lifestyle management [9,10].
This seems too narrow a focus, as there is also room for
improvement in the detection and treatment of emotional
problems in the chronically ill [4,11,12].
Our study intends to facilitate a shift towards a chronic
care approach that combines attention to both biomedical
and psychosocial aspects. We believe that equipping prac-
tice nurses (PNs) with the ability to provide this might be
an effective way to realise such a biopsychosocial approach
in chronic care [13]. PNs in the Dutch primary care set-
ting see patients on a regular basis, as they have the task
of providing routine check-ups [14]. Since diabetes pa-
tients were the first to be cared for by PNs, we aim to
integrate an existing nurse-led minimal psychological
intervention (MPI) in the diabetes follow-up care by PNs.
The nurse-led MPI has proved to be effective in supporting
the self-management skills of diabetes and COPD patients
with minor to moderate depression [15-18].
The MPI can only be adopted by PNs if a detection
method is added that enables PNs to distinguish between
patients who are active self-managers, patients who would
benefit from the psychosocial support, and patients who
need more specialised psychosocial diagnostics or treat-
ment. We call the resulting stepped approach to detec-
tion and treatment ‘Self-Management Support’ (SMS).In addition to adapting the MPI to become SMS, we need
to arrange for a training course with booster sessions, and
ensure the allocation of time and organisational support
to enable the PNs to adopt SMS in their current practice.
For a thorough understanding of the effectiveness of SMS,
the facilitators and barriers to its implementation in
routine care need to be taken into account. Therefore,
we want to start a hybrid effectiveness–implementation
trial to examine the effectiveness of SMS in terms of pa-
tient outcomes, and focus on implementation outcomes.Aim
The aim of our study is to evaluate the process and effect-
iveness of SMS implemented as an integral part of the
care for patients with type 2 diabetes mellitus provided
by PNs. We will simultaneously address the following
research questions:
1. What is the uptake of the SMS programme by the
practice nurses, and what barriers hamper the
implementation of SMS in routine primary care?
(Study of the implementation strategies for SMS.)
2. What is the effectiveness of SMS in terms of daily
functioning, emotional health status, social
participation, self-management behaviour, and
health care use by patients with type 2 diabetes?
(Study of the SMS clinical intervention.)
The effectiveness of SMS (question 2) will be considered
while taking the barriers to the implementation process
(question 1) into account.
Methods/Design
In our study, we will use a hybrid effectiveness–
implementation design to focus on implementation issues
and the effectiveness of SMS at the same time. Curran
and colleagues have presented a continuum of three
types of such hybrid effectiveness–implementation (E-I)
study designs [19], ranging from effectiveness research
with minimal implementation strategies (type 1) to de-
signs where effectiveness and implementation are equally
balanced (type 2) and an implementation approach with
minimal focus on effectiveness outcomes (type 3). We will
examine the effects of SMS on patient outcomes and
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it is a type 2 hybrid E-I study design.
Below, we first describe our implementation strategies
(intervention) and then explain our evaluation methods
regarding the implementation and effects of SMS in rou-
tine care (evaluation).Intervention
In a previous study, the nurse-led minimal psychological
intervention (MPI) was carried out by trained research
nurses [20]. In our present study, practice nurses who
provide diabetes care will have to adopt the MPI in their
current practice. This required changes with regard to the
clinical intervention as well as the organisational context
in which the intervention will be integrated [21]. This sec-
tion explains the steps that will be taken to implement the
resulting SMS in routine diabetes care.
Implementation strategy 1: adaptation of clinical intervention
The nurse-led MPI has been altered from a ‘research
object’ to an intervention that can be systematically em-
bedded in routine primary care. Adaptations were needed
regarding the target group, providers, detection of eligible
patients and self-management support. The shift from
MPI to SMS is summarised in Table 1.
Target group The original effective nurse-led MPI was
provided specifically to patients with a diagnosis of de-
pression, whereas a wide range of psychological and social
problems occur in a routine primary care setting. What
primarily matters in daily practice is to what extent pa-
tients experience problems of daily functioning [12]. SMS
was therefore designed for chronic patients who encoun-
ter problems of daily functioning and emotional distress.
Providers Instead of research nurses providing the inter-
vention as an add-on to usual care, SMS will be integrated
in usual care provided by PNs. PNs work in general prac-
tice under supervision of a GP. They see type 2 diabetes
patients every 3 months for a diabetes check-up. SMS is
to become an integral part of these check-ups.Table 1 The SMS approach contrasted with the original MPI
MPI
Target group Chronic patients with mild or n
major depression
Providers Research nurses not involved in
Diagnostic approach For research purposes. Using an
interview, following strict psych
Self-management support intervention 1. cognitive therapy (reattributi
2. problem solvingDetection procedure The diagnostic procedure that was
used to recruit patients for the study to evaluate the ori-
ginal MPI is not feasible in routine primary care: it was
limited to depression, and included an extensive and
time-consuming diagnostic interview (the Mini Inter-
national Neuropsychiatry Interview) to confirm a diag-
nosis of depression according to psychiatric criteria. For
SMS, PNs will have to decide during routine diabetes
check-ups whether watchful waiting, offering psycho-
social self-management support or a referral to the GP
because of symptoms of mental health problems is most
appropriate. Therefore, we have introduced a stepped
approach that allows interventions not sooner or more
intense than necessary and not later or less intense than
required. The approach is as follows. During each regu-
lar diabetes check-up, PNs will explore whether the pa-
tient is experiencing problems in daily life. Then they
verbally administer the ‘Daily Functioning Thermometer’
(DFT), a visual analogue scale to rate the overall burden
of diabetes. (See the Measurements section below for
more information about the instruments.) Practice nurses
will also verbally administer the 3-item Distress Screener
(DS), a quick-scan instrument for emotional distress
and an indicator of potential underlying severe mental
health problems [22]. Patients with DS > 3 will be asked
to complete the Four-Dimensional Symptom Question-
naire (4DSQ) [23] immediately after the consultation.
This self-report measure is widely used in Dutch primary
care to distinguish non-specific general distress from
depression, anxiety and somatisation. Scoring the 50 items
of the 4DSQ should take 5–10 minutes The completed
4DSQ will be returned to the PN, who will score the
4DSQ using a scoring form. Patient’s scores on the 4DSQ
will distinguish between mild, moderate and severe mental
health problems. Patients who experience problems of
daily functioning (DFT > 4) and emotional health prob-
lems (DS > 3 combined with moderate scores on subscales
of the 4DSQ) will receive self-management support from
the PN. If a patient has only ‘mild’ scores on the 4DSQ,
the PNs will opt for watchful waiting. The same option will
be used for patients with moderate scores on the 4DSQ
who do not report problems of daily functioning due toSMS
on-severe Chronic patients with emotional distress and
problems of daily functioning
usual care Practice nurses providing usual chronic care
extensive diagnostic
iatric criteria
As part of daily care. Using simple tools,
following a stepped care approach that fits
the primary care setting
on) 1. problem solving
2. cognitive therapy (reattribution)
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telephone that there is as yet no indication for extra con-
sultations. Patients with a ‘severe’ score on at least one of
the subscales will be referred to the GP. The detection
protocol is summarised in Table 2.Self-management support programme The self-
management support by the PN will be provided during
extra 20-minutes consultations. Its aim is to teach patients
to take responsibility for the day-to-day management of
their diabetes and its consequences. This self-management
support is based on the MPI. The intervention strategy has
been derived from principles of learning theory and has
been described elsewhere [24]. PNs will help patients to
define problems and solutions themselves, applying the
techniques of problem-solving and reattribution. Problem-
solving consists of 7 stages that efficiently address psycho-
social problems and their possible solutions [25]. It starts by
creating a link between emotional symptoms and problems,
and explaining the rationale of the treatment: resolution
of the problems may lead to resolution of the symptoms
(step 1).
Step 2 involves clarifying and defining the problem. The
third step is to set achievable goals. Once an achievable
goal has been set, the patient will be asked to brainstorm
about all potential solutions (step 4). Step 5 involves
considering the pros and cons and selecting a preferred
solution. In step 6, the solution will be implemented in
daily life, and step 7 involves evaluating the progress. The
problem-solving approach can easily be understood by pa-
tients and can also easily be taught to practice nurses [25].
Patients with strong emotional involvement will be sup-
ported using the reattribution technique. This starts by
exploring and defining the patient’s problem, after which
the patient is challenged to link cognitions to behaviour.
To this end, patients may keep a diary to record thoughts,
behaviours and related feelings. After possibilities to alter
specific behaviours have been explored, an action plan will
be formulated indicating how the goals can be achieved
[20]. If specific problems appear to be persistent and ser-
ious over time, action will be undertaken to provide more
specialised care. PNs are instructed to refer these patients
to the GP.Table 2 Detection protocol
DFT≤ 4 DFT > 4
DS≤ 3 No indication Watchful waiting
DS > 3 On the basis of the 4DSQ: On the basis of the 4DSQ:
Mild: watchful waiting Mild: watchful waiting
Moderate: watchful waiting Moderate: self-management
support by PN
Severe: referral to GP Severe: referral to GPIn the original MPI, the cognitive approach appeared to
benefit more highly educated patients more than lower
educated ones [18]. The SMS will be implemented in a re-
gion in the south of the Netherlands that is characterised
by relatively low socio-economic status [26], so in order to
increase the benefit for patients with low socio-economic
status, we will put greater emphasis on the problem-
solving technique during the training of PNs.
A flowchart of SMS is presented in Figure 1.
Implementation strategy 2: involvement of regional GP
organisation
SMS will be implemented in one region in the south of
the Netherlands. A group of 77 general practices (103 GPs)
in the region, who collaborate in a GP organisation, was
involved from the beginning of the SMS project, and
they have prioritised the integration of SMS in the care
for type 2 diabetes patients. The GPs are responsible for
about 16,000 patients with type 2 diabetes mellitus. The
region is characterised by relatively low socio-economic
status, health status and life expectancy and substantial
ageing of the population [26,27]. Based on earlier research
findings we estimate that as many as 2400 patients
with type 2 diabetes mellitus (15%) may suffer from
emotional distress accompanied by problems of daily
functioning [28].
Implementation strategy 3: financial support
The reimbursement of diabetes care in the Netherlands
is regulated by means of diagnosis-treatment combina-
tions (DTC), a Dutch variant of the Diagnosis Related
Groups [29]. For each care group, health insurers’ purchase
integrated care by negotiating a fixed price per patient per
year. The elements of care with corresponding tariffs are
defined in a shared care protocol. This is driven by the
Dutch ‘care standard’ for diabetes [9], which is based on
existing guidelines, protocols and performance indicators.
During the study, a health insurance company will reim-
burse the extra time spent on SMS by practice nurses and
GPs. The reimbursement will be integrated in the DTC for
diabetes care.
Implementation strategy 4: training
The PNs in the intervention group will be trained to carry
out SMS in three 8-hour training sessions. The training
programme is based on a nurses’ training course that has
been shown to be feasible, attractive and successful. PNs
learn how to help patients identify their problems and set
achievable goals [24]. The training programme will also
focus on exploration skills. PNs will learn to use instru-
ments to establish the severity of psychosocial problems
in a stepped approach (first DFT and DS, and if appro-
priate further exploration using 4DSQ). The training ses-
sions will take place in small groups, to facilitate active
3-monthly  
diabetes consultation 
Moderate problems on 4DSQ 
with DFT  4 
Exploration of problems 





Referral to GP 
Moderate problems 
on 4DSQ 
DFT > 4 
Severe problems  
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DFT 0 - 10 
Extra consultation(s) 
Self-management support 
Psychosocial problem Strong emotional involvement 
Reattribution
1. Problem definition 
2. Linking cognitions to behaviour,  
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3. Action plan 
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1. Explanation of treatment and 
its rationale, formulation of 
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2. Clarification and definition 
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Mild problems on 4DSQ 
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Figure 1 Flowchart for SMS intervention.
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three training sessions will be followed up by booster ses-
sions and telephone consultations, whose frequency will
depend on the PNs’ needs. Booster sessions will be used to
maintain and improve the PNs’ SMS skills. PNs will make
audiotapes during consultations, which will be reflected on
during booster sessions.
Implementation strategy 5: registration system for SMS
SMS will be integrated in the registration system that
GPs and PNs use for diabetes care. The steps to be taken
during the detection phase of SMS as well as the differ-
ent stages of the self-management support by the PN are
displayed in the regular registration system. PNs will rec-
ord how patients rate their burden of diabetes (DFT), as
well as their scores on the distress screener (DS). This in-
formation will be displayed at the next diabetes check-up.The system also helps PNs compute the outcomes of
the 50-item Four-Dimensional Symptom Questionnaire
(4DSQ). The PNs will also record the self-management
support steps that are taken during each consultation,
and the patients’ action plans.
Evaluation of the implementation process
Design
A process evaluation will be done to analyse the facilita-
tors and barriers regarding integration of SMS in routine
care. We will gather quantitative and qualitative data
about the intervention as an integral part of the routine
diabetes care, as well as about the health professionals
(PNs and GPs) and patients, and the impact of SMS on
the practice organisation and the community [30]. How
SMS has been implemented and received by the par-
ticipants will be measured by means of the following
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[31]: fidelity, dose delivered, dose received, reach, recruit-
ment and context. In addition, the costs of implementing
SMS in routine care will be assessed. The process evalu-
ation will include formative evaluation with respect to the
new components of the clinical intervention, as these as-
pects may need to be refined or optimised to make them
fit the local setting.
Variables and measurements
Fidelity refers to the extent to which SMS has been
implemented as planned. At each diabetes consultation,
the PNs will record which steps of the SMS protocol
have been carried out. The outcomes on the DS, DFT
and 4DSQ, the choices that have been made regarding
further treatment and the patients’ action plans will also
be recorded. The registration system also offers room
for comments. PNs will be asked to give an explanation
if they deviate from the SMS protocol.
Dose delivered is measured as the number of compo-
nents of SMS per patient that have been carried out as
intended. Data will be derived from the registration system.
Dose received includes two components: satisfaction
and exposure.
Exposure refers to the extent to which participants
(patients and health professionals) are actively engaged
with the SMS programme and use the tools of SMS in
daily practice. Engagement and satisfaction of partici-
pants will be measured among the providers (PNs and
GPs) and among the patients.
PNs will be asked to complete an evaluation form after
the training sessions, with questions about the clarity of
wording of the components of the training course. With
regard to the integration of SMS in routine diabetes
consultations, issues discussed with PNs during booster
sessions will be recorded during the follow-up period.
This will provide qualitative information about the bar-
riers and facilitators that PNs may experience. At the end
of the follow-up period (one year after the SMS training
course), we will develop a questionnaire including all the
barriers and facilitators that have been discussed during
the booster sessions. PNs will be asked to individually rate
all these issues.
The engagement and satisfaction of GPs will be evalu-
ated by means of self-administered questionnaires. All par-
ticipating GPs from the intervention arm will be asked
about their involvement in the SMS programme and their
views on the impact of SMS for their practice.
How patients experience being involved in the SMS
programme will be explored in detail by holding semi-
structured interviews with a purposive sample of pa-
tients who have received the SMS from their PN. These
interviews will be held during the follow-up period. The
topics include patients’ experiences with the detectionphase of SMS, the self-management support, the oppor-
tunities for and barriers to the implementation of their
action plans in daily life, and their suggestions for im-
provement of the SMS. Interviews with patients will be
audio-taped and transcribed verbatim.
Recruitment refers to the way we have approached and
invited the PNs and GPs to become involved in the pro-
ject to implement and evaluate SMS.
Reach refers to the participation rate and will be mea-
sured as the number of GPs and PNs who actually
participated.
Context refers to the factors relating to the practice,
the community, the social/political context, or other
situational issues that affect either the implementation
of SMS or its outcomes. To examine context issues in
terms of the implementation and effect of SMS, we will
draw up the minutes of meetings with the regional care
group of general practitioners, the health insurer and
our research team.Cost evaluation
We will measure the direct costs of SMS. In addition to
the training and booster sessions, these will include the
time to integrate SMS in routine diabetes consultations.
PNs will record the time they spend on each stage of the
stepped SMS approach.
Data analysis
Data of the implementation study will be analysed by
means of descriptive statistics.
The qualitative interviews with patients will be analysed
by interpretative phenomenological analysis, a framework
that can be used to develop in-depth descriptions of
patients’ experiences. The purpose is to explore the pa-
tients’ perceptions of what is important in relation to
SMS. We will abstract themes and cluster them for each
case [32]. Abstracting and clustering of the themes will be
done independently by two researchers.
Clinical effect evaluation
Design
The effect evaluation of SMS involves a pragmatic 2-armed
cluster-randomised controlled trial (cluster-RCT) with PNs
as the unit of randomisation. Allocation concealment will
be achieved by having an independent experienced re-
search assistant perform a blockwise randomisation using
a random number seed computer program. PNs (n = 46)
will be assigned to an intervention group or control group
at an allocation ratio of 1:1, after stratification into PNs
working alone in a practice, PNs working in a team and
PNs working in different practices. PNs working in the
same general practice will be randomised to the same
trial arm.
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in addition to the usual care, which consists of 3-monthly
diabetes check-ups according to the current guidelines
[10]. PNs in the control arm will be instructed to provide
usual care.
Patients with emotional distress and problems of daily
functioning will be included in the effect evaluation. To
maintain the balance between the intervention and con-
trol groups, a screening procedure will be carried out by
the research centre. A self-administered postal question-
naire will be used to detect eligible patients.
Approval for this study has been obtained from the
Medical Ethics Committee of Maastricht University/
University Hospital Maastricht.
Sample size calculation
Assuming an alpha of 0.05 and a beta of 0.90, an im-
provement in perceived daily functioning (defined as a
score less than or equal to 4 on the Daily Functioning
Thermometer (DFT), our primary outcome) at T12 oc-
curring in 20% of the patients in the intervention group
versus 5% of those in the control group requires at least
a net number of 116 patients per arm (N= 232; 5 patients
per practice nurse). It will be necessary to take account of
a possible dependence between observations on patients
of the same practice nurse. The intra-class correlation
coefficient (ICC) is assumed to be 0.04, a median value
for cluster-RCTs in the primary care setting [33]. Assum-
ing a 30% loss to follow-up [17] we need to recruit at least
331 patients (8 per PN). Since participation in the screen-
ing procedure will not necessarily mean that patients also
give informed consent for the effect evaluation, 10 con-
secutive patients for each PN will be invited to participate
in the effect evaluation (N = 460).
Patient recruitment
All patients with a clinically established diagnosis of type
2 diabetes mellitus who are able to read and write Dutch
will be sent a letter by their GP, explaining SMS and
asking for informed consent to participate. Patients will
receive this letter six weeks before a planned diabetes
consultation with their PN. The enclosed screening
questionnaire will contain the same instruments that PNs
in the intervention group are going to use to detect
whether patients are eligible for the self-management
support, i.e. the ‘Daily Functioning Thermometer’ (DFT)
and the 3-item Distress Screener (DS) [22]. For more in-
formation about these instruments, see the section on
Measurements below. Patients will be asked to return the
completed questionnaire to the research centre and give
informed consent for their data to be used for recruitment
if they are found to be at risk. For each practice nurse, 10
consecutive patients with scores of DFT >4 and DS >3 will
be asked to participate in the study and to give informedconsent for the follow-up measurements. To prevent
bias, PNs will not be notified about the outcomes of the
recruitment procedure.
A flowchart of the trial is shown in Figure 2.
Measurements
To assess the effectiveness of SMS, follow-up measure-
ments will be carried out at baseline and 4 and 12 months
after inclusion. Table 3 provides an overview of the mea-
sures of the effect evaluation and the times of assessment.
Background variables Patient variables that will be
reported are sex, age, year of diagnosis, treatment of dia-
betes (insulin therapy or tablets), marital status and educa-
tion. Furthermore, we will record the age of the PNs, the
number of PNs for diabetes management working in a
general practice, as well as the educational background of
the PNs.
Primary outcome measure The primary outcome will
be daily functioning as measured by means of the Daily
Functioning Thermometer (DFT). This is a visual analogue
scale (VAS) on which patients can rate the overall bur-
den of diabetes on their daily functioning by indicating
a position along a continuous vertical 100 mm line be-
tween 0 (‘no burden at all’) and 10 (‘extreme burden’).
The VAS score is determined by measuring the distance
to the point marked by the patient, in millimetres. The
DFT is comparable to the Distress Thermometer (DT),
an easily understood, valid and feasible self-report meas-
ure of distress used among various groups of cancer
patients [34]. A cut-off score of 4 has been chosen to
differentiate between patients who could benefit from
self-management support by the PN (DFT > 4) and pa-
tients who have apparently found a satisfactory way to
live with the consequences of their diabetes (DFT ≤ 4).
A pilot study among 7 patients with type 2 diabetes
mellitus confirmed the face validity of the DFT.
Secondary outcome measures Three instruments will
assess patients’ emotional health status.
Diabetes-related emotional distress will be measured
by means of the Problem Areas in Diabetes questionnaire
(PAID). This 20-item scale (with five-point Likert scales)
describes common problematic situations for diabetes
patients, each representing a unique area of diabetes-
specific emotional distress. The sum of the scores for
the 20 items is multiplied by 1.25 to get a final score
between 0 and 100. The Dutch PAID has good internal
consistency and validity [35-37].
The Four-Dimensional Symptom Questionnaire (4DSQ)
will be used to measure the presence and severity of men-
tal health problems [23]. The levels of distress (16 items),
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Figure 2 Flowchart for SMS trial. * DFT = Daily Functioning Thermometer. ** DS = Distress Screener.
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past week’. The item scores are summated to obtain scale
scores. The 4DSQ has been found to be a valid self-reported
questionnaire in the primary care setting [23]. For a
more qualitative evaluation of emotional problems that
patients experience, we will use the Psychological Out-
come Profiles (PSYCHLOPS). The PSYCHLOPS asks
patients to describe and score their own emotional health
problems. It is a validated patient-generated measure with
pre-therapy, during-therapy and post-therapy versions.
The instrument is intended to measure individual changes.
It is responsive to change and is internally consistent [38].
Both PSYCHLOPS and 4DSQ explicitly expect patients
to define and rate their emotional health problems. An
increased awareness about their emotional problems of
daily functioning could influence the issues discussed
during the diabetes consultation, which could result in
reduced contrast between the two groups. We will not
use the 4DSQ and the PSYCHLOPS in the control
group at T0, as the timing of the baseline measurementis just before a diabetes consultation, whereas the as-
sessment at T4 is further removed from a diabetes con-
sultation. Inclusion of the PSYCHLOPS and 4DSQ at
both T4 and at the end of the follow-up period (T12)
will provide insight into individual changes. In the inter-
vention group, inclusion of the PSYCHLOPS at baseline
will provide valuable information about the patients’
individual emotional problems. The 4DSQ does not need
to be included in the baseline measurement as it is already
part of the SMS intervention.
Quality of life, i.e. functional health and well-being from
the patient’s point of view, will be measured by means
of the 12-item Short-Form Health Survey (SF-12), a val-
idated subset of the generic health status questionnaire
SF-36 [39,40]. Data will be summarised in 2 scales: a
physical component summary (PCS) and a mental com-
ponent summary (MCS).
Participation and autonomy will be measured by means
of the Impact on Participation and Autonomy (IPA)
questionnaire. The IPA has proved to be valid, reliable
Table 3 Effect evaluation: outcome measures and time of assessment





Daily functioning DFT 1 * * *
Secondary outcomes
Diabetes-related emotional distress PAID 20 * * *
Mental health problems PSYCHLOPS 9 *2 *1 * *
4DSQ 50 * *
Quality of life SF-12 12 * * *
Participation and autonomy IPA 32 + 9 * * *
Job performance SF-HLQ 5 * * *
Self-management knowledge and behaviour PIH-NL 12 * * *
General self-efficacy GSES-12 12 * * *
Control over the disease Average blood glucose
level (HbA1c)
1 *
Health care use 5 * * *
Covariates
Patient demographics Sex 1 *
Age 1 *
Year of diagnosis 1 *
Treatment of diabetes 1 *
Marital status 1 *
Education 1 *
Practice nurse demographics Age 1 *
Training 1 *
Type of general practice(s)
(one GP, two GPs, group, health centre)
1 *
1 Only patients in intervention arm. Risk of contamination.
2 Only eligible patients (Distress Screener > 3).
* = measuring moment.
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point Likert scales) cover five domains of participation:
‘autonomy indoors’, ‘family role’, ‘autonomy outdoors’,
‘social life and relationships’ and ‘work and education’.
A score for each subscale will be calculated. In addition,
9 items will evaluate the extent to which limitations are
experienced as problematic: ‘no problems’, ‘minor prob-
lems’ or ‘major problems’. These items will be scored sep-
arately [42].
Five items from the Short-Form Health and Labour
Questionnaire (SF-HLQ) will be used to measure difficulties
of job performance due to health problems. The SF-HLQ is
a generic and validated measurement to collect data about
productivity loss relating to health problems [43].
Patients’ self-management knowledge and behaviours
regarding their diabetes will be measured by the Partners
in Health (PIH) scale [44]. This scale reliably and validlymeasures aspects of patient progress within a self-
management programme for a chronic condition. We will
use the Dutch version (PIH-NL). The 12 items (0–8 Likert
scales with 0 indicating high self-management and 8 low
self-management) cover four domains of patients’ compe-
tency in relation to the self-management of their chronic
condition (knowledge, coping, management of condition
and adherence to treatment).
The General Self-Efficacy Scale (GSES-12) will be used
to assess the patients’ belief in their ability to organise
and engage in certain behaviours. The sum score of the
12 items (five-point Likert scales) reflects an internally
consistent and stable unidimensional construct of gen-
eral self-efficacy [45,46].
At each diabetes consultation, the blood glucose level
over the past 2 to 3 months (HbA1c) will be measured
and recorded in the registration system.
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fers to individual numbers of visits to the general practice,
specialist referrals and admissions, mental health care
consultations, use of home care and hours of paid and un-
paid household help. Patients will record their health care
use retrospectively (over the last month) in the patient
questionnaires administered at baseline and after 4 and
12 months. Data about referrals to the GP, and the num-
ber of contacts with the general practice will be collected
from the GP’s registration system.
Data analysis of the effect evaluation
The effectiveness of SMS will be assessed by intention-
to-treat analyses. The comparability of patients in the
intervention and control groups regarding baseline char-
acteristics and demographics will be described and tested
for significant differences (t-tests and Chi-square tests).
The average changes in DFT score will be calculated, as
well as the number of patients that have DFT ≤4 after
receiving SMS (T4 and T12). Separate scores will be cal-
culated for the subscales of the secondary outcome
measures. Changes in the primary and secondary out-
comes between the intervention and control groups will
be analysed using multilevel analyses (linear and logistic
regression methods) as this will account for intracluster
correlation among PNs. Multivariate regression analyses
will be used to adjust the results for co-variables such as
patient characteristics (age, sex, socio-economic status)
and PN characteristics (age, educational background).
Discussion
This paper describes a study protocol to implement and
evaluate an evidence-based, nurse-led minimal psycho-
logical intervention (MPI) in routine diabetes care in the
Dutch primary care setting. The intervention itself has
already been found to be an effective and cost-effective
method to improve self-management by chronic patients
with mild to moderate depression, but its effect was
evaluated in a trial with standardised conditions regard-
ing the inclusion of patients, and the care was delivered
by research nurses [20]. Both GPs and a health insurer
have prioritised the inclusion of the MPI in routine dia-
betes care, so there was an ‘implementation momentum’
within the system [19]. Actually making this happen re-
quired adaptations to be introduced regarding providers,
target group and detection procedure. The new approach
has been named Self-Management Support (SMS).
Our hybrid design and its potential
The effects of integrating SMS in the routine primary care
setting can only be evaluated when it is implemented in
the ‘real world’; the implementation strategies will be de-
cisive for the success of SMS at the practice and patient
levels. The essential adjustments to the intervention withregard to both providers and recipients require further
insights into the effectiveness of SMS. An understanding
of both the prerequisites of integrating SMS in routine
care and the effectiveness of SMS is essential for future
planning. In terms of the continuum of design types pro-
posed by Curran and colleagues [19], our study is an ex-
ample of a type 2 hybrid effectiveness–implementation
(E-I) study design. The effects and the implementation
process will be evaluated simultaneously.
Curran and colleagues [19] argue that the combination
of two study designs in a hybrid study may have the po-
tential to accelerate the translation of research into rou-
tine practice. They refer to the dominant approach of
translating research into practice that starts with clinical
efficacy research, then clinical effectiveness research, and
finally implementation research. The potential for rapid
integration of research into practice is also apparent in
our study. SMS evolved from a joint endeavour of the
regional care organisation of general practitioners, the
health insurer and the evaluators. The intervention has
been developed as a generic approach to support patients’
self-management. The outcomes of the implementation
and evaluation of SMS will provide a broad perspective on
barriers, facilitators and effects of the detection and treat-
ment of psychosocial problems by PNs in chronic care.
Hence, if SMS appears to be successfully implemented
and has relevant effects, it could in the near future also be
applied to patients with other chronic conditions. The
shared vision of stakeholders regarding SMS and their
involvement in the development and evaluation is expected
to facilitate a rapid large-scale integration of SMS in
routine care.
Our hybrid design and its methodological challenges
In hybrid E-I studies, the world of implementation science
has to combine with the tradition and vocabulary of re-
searchers from clinical research backgrounds. This implies
a complex balance in the design itself between internal
validity and factors associated with implementation, but
also can be an obstacle to funding and publication [19,47].
Our study involves an additional methodological issue
with respect to hybrid design, viz. the new detection
method that is introduced in our study to integrate the
original MPI in routine care. Its feasibility in routine dia-
betes consultations is not yet known, and needs to be eval-
uated as part of our process evaluation. However, an
adequate detection method is also a prerequisite for clin-
ical effectiveness of SMS. The methodological issues re-
garding the detection method are further explained below.
In order to integrate the MPI in the daily care by prac-
tice nurses, we had to introduce a new detection method
to fit the primary care setting. The MPI has been adapted
to become a self-management intervention for patients
with problems of daily functioning and emotional distress.
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tect patients with these psychosocial problems, we have
introduced new instruments in the form of the Distress
Screener and the Daily Functioning Thermometer, and de-
fined the cut-off criteria. The Distress Screener and the
Daily Functioning Thermometer are assumed to be valid
for the early detection of patients with emotional distress
and problems of daily functioning [22,34]. These instru-
ments will be integrated into the routine diabetes con-
sultations provided by PNs. Our implementation strategies
(i.e. providing training, financial support and a registration
system) will determine whether PNs are able to integrate
the instruments in their daily practice. Evaluation of the
implementation process will show what numbers of pa-
tients are detected, whether patients with problems of
daily functioning (according to the DFT) and with moderate
psychological problems (according to the Four-Dimensional
Symptom Questionnaire, 4DSQ) are representative of the
group of patients that are in need of the self-management
support, and to what extent PNs have the skills to inte-
grate the tools in their routine consultations. The feasi-
bility, power and success of our detection method are
unknown and will determine the success and feasibility
of the whole SMS approach.
The detection method will an integral part of the tasks
of the PNs during a routine diabetes consultation. PNs
will be given a reasonable degree of freedom in applying
the detection method in their consultations, as we use a
pragmatic approach without strict internal controls. We
aim to avoid interference of research activities with daily
practice as much as possible, which has implications for
the recruitment of patients for the effect evaluation.
In theory, all diabetes patients of the PNs would be
eligible for participation in the effect evaluation of SMS,
as the PNs will apply the detection part of SMS in every
diabetes consultation. However, we have chosen to limit
the effect evaluation to patients with actual problems of
daily functioning and emotional distress. This will in-
crease the contrast between the intervention and control
groups, so we need to include patients that are likely to
be detected during regular care and receive further
treatment. We had to set up a researcher-led parallel
screening procedure to detect eligible patients from
both the intervention and control groups. Based on our
pragmatic approach, the conditions for this screening
procedure are:
1. The self-administered screening questionnaire is
sent to the patient’s home address and includes the
instruments that PNs apply during consultation.
2. The screening does not interfere with daily practice
in the control arm. As the DFT and DS consist of
simple and generic questions, we do not expect any
interference with daily care.3. The time interval between the researcher-led
screening and the nurse-led detection procedure
needs to be limited. We have decided to send the
screening questionnaire six weeks before the
individual diabetes consultation appointment.
However, we cannot avoid the risk that natural fluctua-
tions in the emotional health status of patients will result
in different outcomes on the DFT and DS in the nurse-led
detection compared to the researcher-led postal screening.
The time interval could become too long, for example if
a consultation appointment is cancelled. We thus have
to take into account that conclusions based on the
researcher-led screening questionnaires will not always
correspond to those of the same instruments applied by
the PNs during the consultations. As a consequence, a
certain number of patients in our study sample will only
be exposed to the detection part of SMS, without receiv-
ing follow-up treatment, while some patients who are
not included in the effect evaluation may receive the
self-management support. This may reduce the contrast
between the intervention and control arms.
In conclusion, the strength of the clinical effectiveness
evaluation in our study greatly depends on two risk fac-
tors of our hybrid design:
1. the extent to which PNs are able to detect patients
who need the self-management support; and
2. the match between the patients who are detected by
the researcher-led screening and those detected by
the PN.
If PNs in our study would, for any reason, not detect
or not treat patients who are recruited for the effect
evaluation on the basis of the researcher-led screening,
it may become difficult to demonstrate the clinical ef-
fectiveness of SMS. Nevertheless, the clinical effective-
ness outcomes of SMS integrated in routine care are
very important for decisions about future planning and
(financial) support for SMS. If we are unable to demon-
strate clinical effectiveness of SMS, the speed of transla-
tion of the evidence-based intervention into routine care
may even be threatened due to the methodological is-
sues of a hybrid effectiveness–implementation design.
We will try to minimise the risks by providing training
to PNs, followed by booster sessions, using a formative
evaluation method that gives us the opportunity to refine
the detection procedure, and by a researcher-led screening
that closely resembles the detection at the consultation in
terms of timing and procedure.
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